Trident Lifeline Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹500 Cr
- P/E
- 22.05
- ROE
- 22.56%
- PEG
- 0.48
- Price to sales
- 3.20
- Debt to equity
- 0.79
- 52W high / low
- ₹434 / ₹238
- EBITDA margin
- 22.96%
- Net profit margin
- 14.64%
- Promoter holding
- 62.53%
- Sales (last year)
- ₹156 Cr
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Financials of Trident Lifeline
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Trident Lifeline
Quarterly Results
Quarter-by-quarter operating performance
Financials of Trident Lifeline
Profit & Loss
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 22 | 32 | 45 | 87 | 129 |
| Expenses + | 19 | 25 | 36 | 72 | 101 |
| Operating Profit | 3 | 6 | 8 | 15 | 28 |
| OPM % | 12% | 20% | 18% | 17% | 22% |
| Other Income + | 1 | 1 | 2 | 8 | 9 |
| Interest | 0 | 0 | 1 | 4 | 4 |
| Depreciation | 0 | 0 | 1 | 5 | 6 |
| Profit before tax | 3 | 7 | 9 | 14 | 27 |
| Tax % | -32% | 8% | 32% | 23% | 29% |
| Net Profit + | 4 | 6 | 6 | 10 | 19 |
| EPS in Rs | 4.94 | 5.24 | 5.51 | 10.22 | 15.96 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Trident Lifeline
Balance Sheet
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 8 | 12 | 12 | 12 | 12 |
| Reserves | -3 | 34 | 41 | 53 | 88 |
| Borrowings + | 2 | 8 | 18 | 54 | 73 |
| Other Liabilities + | 7 | 9 | 16 | 37 | 63 |
| Total Liabilities | 14 | 63 | 87 | 156 | 237 |
| Fixed Assets + | 1 | 3 | 21 | 44 | 61 |
| CWIP | 0 | 5 | 4 | 2 | 18 |
| Investments | 0 | 3 | 4 | 11 | 8 |
| Other Assets + | 12 | 51 | 58 | 99 | 150 |
| Total Assets | 14 | 63 | 87 | 156 | 237 |
Financials of Trident Lifeline
Cash Flows
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -0 | -19 | 2 | -10 | 5 |
| Cash from Investing Activity + | -0 | -10 | -20 | -14 | -37 |
| Cash from Financing Activity + | 1 | 42 | 11 | 20 | 34 |
| Net Cash Flow | 0 | 14 | -7 | -4 | 2 |
| Free Cash Flow | -1 | -26 | -16 | -21 | -29 |
| CFO/OP | -8% | -294% | 56% | -38% | 45% |
Financials of Trident Lifeline
Ratios
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 83 | 139 | 110 | 116 | 208 |
| Inventory Days | 95 | 129 | 156 | 226 | 174 |
| Days Payable | 134 | 87 | 94 | 119 | 183 |
| Cash Conversion Cycle | 44 | 182 | 173 | 224 | 199 |
| Working Capital Days | 49 | 275 | 205 | 144 | 134 |
| ROCE % | 23% | 15% | 18% | 21% |
Momentum score · price trend
91 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,908 stocks |
|---|---|---|
| Last 12 months | +48.5% | 84% |
| Last 6 months | +72.2% | 93% |
| Last 3 months | +60.1% | 98% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,908 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Trident Lifeline: 0.4 × 84 + 0.4 × 93 + 0.2 × 98 = 91.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.